SIMPLEX TRADING, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 90 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 1.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$84
+366.7%
55,985
+166.6%
0.00%
Q4 2023$18
-35.7%
21,001
-2.3%
0.00%
Q3 2023$28
-52.5%
21,506
+23.6%
0.00%
Q4 2022$59
-99.8%
17,405
+199.4%
0.00%
Q3 2022$31,000
+3.3%
5,814
-15.4%
0.00%
Q2 2022$30,000
-92.0%
6,871
-88.3%
0.00%
Q4 2021$377,000
+18750.0%
58,733
+20580.6%
0.00%
Q2 2021$2,000284
-90.9%
0.00%
Q1 2021$0
-100.0%
3,110
-72.7%
0.00%
Q4 2020$176,000
+16.6%
11,405
+9.7%
0.00%
Q3 2020$151,000
-59.4%
10,400
-47.2%
0.00%
-100.0%
Q2 2020$372,000
-25.3%
19,689
-24.3%
0.00%0.0%
Q4 2019$498,000
+3730.8%
26,019
+1797.8%
0.00%
Q3 2019$13,000
-95.5%
1,371
-97.2%
0.00%
-100.0%
Q2 2019$288,000
+317.4%
48,107
+301.4%
0.00%
Q1 2019$69,000
-59.2%
11,985
-33.7%
0.00%
Q4 2018$169,000
+634.8%
18,078
+1208.1%
0.00%
Q3 2018$23,000
-92.1%
1,382
-93.7%
0.00%
-100.0%
Q1 2018$292,000
+363.5%
21,808
+228.1%
0.01%
+333.3%
Q4 2017$63,000
-69.7%
6,646
-65.0%
0.00%
-62.5%
Q3 2017$208,000
-57.0%
19,004
-49.6%
0.01%
-61.9%
Q1 2017$484,000
+2588.9%
37,733
+1756.9%
0.02%
+2000.0%
Q1 2016$18,000
-50.0%
2,032
-27.0%
0.00%
-66.7%
Q4 2015$36,000
-71.4%
2,784
-76.9%
0.00%
-66.7%
Q3 2015$126,000
+740.0%
12,057
+2056.9%
0.01%
+800.0%
Q2 2015$15,000
-25.0%
559
+3.7%
0.00%
-50.0%
Q4 2014$20,0005390.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,827,078$82,205,0004.43%
Palo Alto Investors LP 4,663,324$79,416,0003.21%
Private Capital Advisors, Inc. 473,901$8,071,0002.23%
DOHENY ASSET MANAGEMENT /CA 215,445$3,669,0001.92%
Sandia Holdings, LLC 119,739$2,039,0000.96%
Capital Impact Advisors, LLC 102,006$1,744,0000.60%
Birchview Capital, LP 50,000$852,0000.55%
EMERALD ADVISERS, LLC 694,068$11,820,0000.43%
EMERALD MUTUAL FUND ADVISERS TRUST 647,307$11,024,0000.37%
Schonfeld Strategic Advisors LLC 418,100$7,121,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders